The New York Times, August 6, 2015
Last year, scientists launched a trial of an experimental vaccine against Ebola in Guinea. On Friday, they reported great news: The vaccine works well, providing remarkable protection just 10 days after injection.
“We have to stop and celebrate the fact that an innovative trial design was able to come up, in the middle of an emergency, with pretty strong results,” said Dr. Seth Berkley, the chief executive officer of Gavi, an alliance of public and private organizations that provides greater access to vaccines in developing countries. “Let’s start with that.”
But let’s not end with that.
Continue reading “For Vaccines Needed in an Epidemic, Timing Is Everything”